Oxagen

Oxagen is a biopharmaceutical company building a novel drug pipeline based on targets validated in man through its genetics platform. The Company specialises in target identification and validation in inflammatory and metabolic diseases and is creating a pipeline of novel, highly validated drug targets for licensing to partner companies and for in house development, together with panels of molecular diagnostic markers. Oxagen has built up unique family-based clinical genetics resources in its key therapeutic areas.